CHIP ahoy:在克隆造血过程中的十年发现
Casey K Wong1, Alexandra McDonald2, Marco M Buttigieg1
1Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON.
Haematologica
|September 4, 2025
概括
克隆造血 (CH) 涉及与骨髓性恶性瘤相关的干细胞的年龄性突变. 测序和建模方面的进步改善了检测,指导了针对性治疗和早期干预的风险分层.
科学领域:
- 血液学
- 遗传学
- 癌症学
背景情况:
- 克隆性造血 (CH) 的特征是具有获得突变的造血干细胞的扩张.
- 这种疾病与骨髓瘤和心血管疾病的风险增加有关.
- 了解CH驱动因素对于早期检测和干预至关重要.
研究的目的:
- 审查检测克隆造血驱动器的进展.
- 探索CH在骨髓瘤和固体瘤中的临床影响.
- 突出CH管理和治疗策略的不断变化.
主要方法:
- 下一代测序和单细胞测序用于变种检测.
- 分析CH驱动器的计算建模.
- 对CH遗传学,临床影响和治疗试验的当前文献的审查.
主要成果:
- 先进的测序技术提高了CH驱动器的检测灵敏度,包括体和生殖系变异.
- 在固体瘤中,CH会影响瘤微环境,治疗反应和并发症.
- 风险分层模型和正在进行的试验正在为主动的CH管理铺平道路.
结论:
- 通过CH研究,人们对其生物学和临床相关性有了更深入的了解.
- 针对性治疗和个性化干预正在根据CH风险进行开发.
- 该领域正在转向早期检测,精确治疗和预防CH相关疾病.
相关概念视频
Hematopoiesis
5.6K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.6K
Overview of Hematopoiesis
4.7K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
4.7K
Lineage Commitment
3.1K
Commitment is the process whereby stem cells:
3.1K
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Multipotency of Hematopoietic Stem Cells
3.3K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.3K
Differentiation of Common Myeloid Progenitor Cells
3.3K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.3K


